Expression and localisation of the pyrophosphate transporter, ANK, in murine kidney cells

Cellular Physiology and Biochemistry

Volumn 20, Issue 5, 2007, Pages 507-516

  Carr, Georgina ^a   Sayer, John A ^a,b   Simmons, Nicholas L ^a,b  

^a Epithelial Cell Research Group Institute for Cell and Molecular Biosciences   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

ANK; Inner medulla; mIMCD 3 cells; Mitochondria; Pyrophosphate; Renal stone formation

Indexed keywords

ANK PROTEIN; AQUAPORIN 2; CALCIUM; HYBRID PROTEIN; PROTEIN; PYROPHOSPHATE; UNCLASSIFIED DRUG; WHEAT GERM AGGLUTININ;

ANIMAL CELL; ANIMAL TISSUE; APICAL MEMBRANE; ARTICLE; CELL LEVEL; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENDOSOME; GENETIC TRANSFECTION; GOLGI COMPLEX; IMMUNOHISTOCHEMISTRY; KIDNEY CELL; MEMBRANE TRANSPORT; MITOCHONDRION; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WILD TYPE;

MURINAE; MUS; TRITICUM AESTIVUM;

EID: 34548328249     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107534     Document Type: Article

References (24)

1. Smith LH: The medical aspects of urolithiasis: an overview. J Urol 1989;141:707-710.
2. Sayer JA, Carr G, Simmons NL: Nephrocalcinosis:molecular insights into calcium precipitation within the kidney. Clin Sci 2004;106:549-561.
3. Bushinsky DA: Nephrolithiasis: site of the initial solid phase. J Clin Invest 2003;111:602-605.
4. Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M: Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 2003;59:975-983.
5. Costa-Bauza A, Isern B, Perello J, Sanchis P, Grases F: Factors affecting the regrowth of renal stones in vitro. Scan J Urol Nephrol 2005;39:194-199.
6. Yuzawa M, Tozuka K, Tokue A: Effect of citrate and pyrophosphate on the stability of calcium oxalate dihydrate. Urol Res 1998;26:83-88.
7. March JG, Simonet BM, Grases F: Determination of pyrophosphate in renal calculi and urine by means of an enzymic method. Clin Chim Acta 2001;314:187-194.
8. Simonet BM, Grases F, March JG: Enzymatic determination of pyrophosphate in urine by flow methods. Anal Sci. 2003;19:1029-32.
9. Ho AM, Johnson MD, Kingsley DM: Role of the mouse ank gene in control of tissue calcification and arthritis. Science 2000;289:265-270.
10. Nurnberg P, Thiele H, Chandler D, Hohne W, Cunningham ML, Ritter H, Leschik G, Uhlmann K, Mischung C, Harrop K, Goldblatt J, Borochowitz ZU, Kotzot D, Westermann F, Mundlos S, Braun HS, Laing N, Tinschert S: Heterozygous mutations in ANKH the human ortholog of the mouse progressive ankylosis gene result in craniometaphyseal dysplasia. Nature Gen 2001;28:37-41.
11. Pendleton A, Johnson MD, Hughes A, Gurley KA, Ho AM, Doherty M, Dixey J, Gillet P, Loeuille D, McGrath R, Reginato A, Shiang R, Wright G, Netter P, Williams C, Kingsley DM: Mutations in ANKH cause chondrocalcinosis. Am J Hum Gen 2002;71:933-940.
12. Canales BK, Leonard SM, Singh JA, Orzano IM, Zimmermann B, Weiland D, Monga M, Krug HE: Spondyloarthropathy: an independent risk factor for kidney stones. J Endourol 2006;20:542-546.
13. Rauchman MI, Nigam SK, Delpire E, Gullans SR: An osmotically tolerant inner medullary collecting duct cell line from an SV40 transgenic mouse. Am. J Physiol 1993;265:F416-424.
14. - conductances of mouse renal collecting duct cells (mIMCD-3). J Physiol 2001;536:769-783.
15. Carr G, Simmons NL, Sayer JA: Disruption of clc-5 leads to a redistribution of annexinA2 and promotes calcium crystal agglomeration in collecting duct epithelial cells. Cell Mol Life Sci 2006;63:367-377.
16. Carr G, Simmons NL, Sayer JA: A role for CBS domain 2 in trafficking of chloride channel CLC-5. Biochem. Biophys Res Comm 2003;310:600-605.
17. Roberts NB, Dutton J, Helliwell T, Rothwell PJN, Kavanagh JP: Pyrophosphate in synovial fluid and urine and its relationship to urinary risk factors for stone disease. Ann Clin Biochem 1992;29:529-534.
18. Lazarowski ER, Bocher RC, Harden TK: Constitutive release of ATP and evidence for major contribution of ectonucleotide pyrophosphatase and nucleotide diphosphokinase to extracellular nucleotide concentrations. J Biol Chem 2000; 275:31061-31068.
19. Gurley KA, Chen H, Guenther C, Nguyen ET, Rountree RB, Schoor M , Kingsley DM: Mineral formation in joints caused by complete or joint-specific loss of ANK function. J Bone Miner Res 2006;21:1238-1247.
20. Laminski NA, Meyers AM, Sonnekus MI, Smyth AE: Prevalence of hypocitraturia and hypopyrophosphaturia in recurrent calcium stone formers. Nephron 1990;56:379-386.
21. 2+ stores? Tren. Neurosci. 2001;24:271-276.
22. Terkeltaub RA: Inorganic pyrophosphate generation and disposition in pathophysiology. Am. J. Physiol. 2001;281:1-11.
23. Zippin JH, Chen Y, Nahirney P, Kamenetsky M, Wuttke MS, Fischman DA, Levin LR, Buck J: Compartmentalisation of bicarbonate-sensitive adenylyl cyclase in distinct signalling microdomains. FASEB J. 2003;17:82-84.
24. Gurley KA, Reimer RJ, Kingsley DM: Biochemical and genetic analysis of ANK in arthritis and bone disease. Am. J. Hum. Genet. 2006;79:1017-1029.